Posts in category

COVID-19


Government accepts ATAGI recommendations for annual free Covid-19 booster shots for adults  Australians aged 18 to 64 years will be eligible for annual Covid-19 jabs, Mark Butler the Minister for …

Here’s how our pandemic experiences have changed over time, writes Deborah Lupton from UNSW Sydney It might be hard to believe, but four years have now passed since the first …

Health workers in public hospitals have protection from abusive members of the public – but community pharmacy is left vulnerable, says a pharmacist who was recently targeted by anti-vaxxers Staff …

One state health department is working with a pharmacy to contact some of its patients, to whom it gave expired Covid vaccines Tasmania’s director of public health, Dr Mark Veitch, …

Record number of Australian patients accessing antiviral treatments for Covid-19  December marked a record month for Covid antiviral use in Australia, with more than 93,000 patients receiving the medications, Chief …

Health Minister says he is “not aware” of issues with supply of antivirals, despite surging case numbers, while deferring to expert advice on calls for widened PBS eligibility  Speaking at …

Monovalent Omicron XBB.1.5 Covid-19 vaccines are now the Australian Technical Advisory Group on Immunisation’s (ATAGI’s) preferred option for individuals aged five years and older   ATAGI has updated its guidance regarding …

The TGA has approved Pfizer and BioNTech’s Omicron XBB.1.5-adapted monovalent Covid-19 vaccine Pfizer and BioNTech SE announced on Wednesday (11 October) that the Therapeutic Goods Administration has authorised their Comirnaty …

A new study has examined behavioural and physical factors which may contribute to the increased risk of Covid-19 amongst health workers Why not to pick your nose: Association between nose …

Government announces a new demographic cohort will have PBS access to an anti-COVID medication The Federal government has announced that, from 1 July, the eligibility criteria for PBS access to …

PBAC recommends extending eligibility criteria for Covid medication to an additional population group    In an out-of-session consideration, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended changes to the circumstances …

Researchers examine the effects of COVID-19-related stock shortages on community pharmacy practice… and warn 60-day dispensing could mean shortages to come This is the fifth in a series of articles …